Epitope distribution in ordered and disordered protein regions. Part B — Ordered regions and disordered binding sites are targets of T- and B-cell immunity
Intrinsically disordered proteins exist in highly flexible conformational states linked to different protein functions. In this work, we have presented evidence that HLA class-I- and class-II-binding T-cell epitopes, experimentally verified in several tumor-associated antigens and nuclear systemic a...
Gespeichert in:
Veröffentlicht in: | Journal of immunological methods 2014-05, Vol.407, p.90-107 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 107 |
---|---|
container_issue | |
container_start_page | 90 |
container_title | Journal of immunological methods |
container_volume | 407 |
creator | Pavlovic, Mirjana D Jandrlic, Davorka R Mitic, Nenad S |
description | Intrinsically disordered proteins exist in highly flexible conformational states linked to different protein functions. In this work, we have presented evidence that HLA class-I- and class-II-binding T-cell epitopes, experimentally verified in several tumor-associated antigens and nuclear systemic autoantigens, are predominantly located in ordered protein regions or at disorder/order borderlines, defined by the majority of analyzed publicly available disorder predictors. We have also observed the overlapping of secondary structural elements and prevalently hydrophobic regions with T-cell epitopes in Epstein Barr Virus (EBV) nuclear antigen 1 (EBNA-1), cancer/testis antigen MAGE-A4, and Sm-B/B′, U1 snRNPA (U1A) and U1-70kDa autoantigens. The results are in accordance with the clustering of the predicted HLA class-I and class-II epitopes in protein parts which encompass the consensus of ordered regions, determined by individual disorder predictors. Some HLA class-II epitopes and linear B-cell epitopes were located near the segments predicted to have elevated crystallographic B factor in EBNA-1, Sm-B/B′ and U1 snRNP A proteins, suggesting that protein flexibility could influence the structural availability of epitopes. Naturally processed T-cell epitopes and linear B-cell epitopes could also be found within putative disordered binding sites, determined by “dips” in the prevalently disordered parts of prediction profiles of the majority of disorder predictors, and peaks in ANCHOR-prediction profile. Two minor antigenic regions within EBNA-1, mapped to the residues 58–85 and 398–458, encompassing putative disordered binding sites, contain epitopes connected with anti-Ro 60kDa and anti-Sm B/B′ autoimmunity in systemic lupus erythematosus. One of these regions overlaps residues 395–450, identified as the binding site of USP7 (HAUSP), which regulates the EBNA-1 replication function. In Sm-B/B′, one of the putative disordered binding sites (residues 114–165) encompasses the T-cell epitope 136–153, while another, residues 200–216, flanks two proline-rich B-cell epitopes (residues 190–198 and 216–222), overlapping the preferred CD2BP2–GYF-binding motif (R/K/G)XXPPGX(R/K), characteristic of splicosomal proteins. We have noticed that the same motif (residues 397–403) is mimicked in EBNA-1 and overlaps epitope 398–404, involved in anti-Sm B/B′ autoimmunity. The majority of recognized T- and B-cell epitopes in analyzed autoantigens or tumor-associated antigens appertain |
doi_str_mv | 10.1016/j.jim.2014.03.027 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1773826366</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022175914001161</els_id><sourcerecordid>1529841903</sourcerecordid><originalsourceid>FETCH-LOGICAL-c386t-3526b37e1bdeed73b746599c7329bd642dbd17e5fa14a0b262212af757794ee93</originalsourceid><addsrcrecordid>eNqFkc1u1DAUhS0EokPhAdggL9kkXNuJHYsVrcqPVKldlLVlxzcjjybJYDtI3fUh2PJyPAmezpRFF2V1ZZ3vHN3rQ8hbBjUDJj9s6k0Yaw6sqUHUwNUzsmKd4pXS0D4nKwDOK6ZafUJepbQBAAYSXpIT3iguO9muyO-LXcjzDqkPKcfglhzmiYaJztFjRE_t5Pfaw3MX54xFjrguYKrptY2ZntE_d7_o1ZE5ao-tLkw-TGuaQsYiRqTZxjXmROeB3lT3-FnV43ZLwzguU8i3r8mLwW4TvjnOU_L988XN-dfq8urLt_NPl1UvOpkr0XLphELmPKJXwqlGtlr3SnDtvGy4d54pbAfLGguOS84Zt4NqldINohan5P0ht5z3Y8GUzRjSfhM74bwkw5QSHZdCyv-jLdddwzSIgrID2sc5pYiD2cUw2nhrGJh9gWZjSoFmX6ABYUqBxfPuGL-4Ef0_x0NjBfh4ALD8x8-A0aQ-4NSjDxH7bPwcnoj_C6WOrZ4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1529841903</pqid></control><display><type>article</type><title>Epitope distribution in ordered and disordered protein regions. Part B — Ordered regions and disordered binding sites are targets of T- and B-cell immunity</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Pavlovic, Mirjana D ; Jandrlic, Davorka R ; Mitic, Nenad S</creator><creatorcontrib>Pavlovic, Mirjana D ; Jandrlic, Davorka R ; Mitic, Nenad S</creatorcontrib><description>Intrinsically disordered proteins exist in highly flexible conformational states linked to different protein functions. In this work, we have presented evidence that HLA class-I- and class-II-binding T-cell epitopes, experimentally verified in several tumor-associated antigens and nuclear systemic autoantigens, are predominantly located in ordered protein regions or at disorder/order borderlines, defined by the majority of analyzed publicly available disorder predictors. We have also observed the overlapping of secondary structural elements and prevalently hydrophobic regions with T-cell epitopes in Epstein Barr Virus (EBV) nuclear antigen 1 (EBNA-1), cancer/testis antigen MAGE-A4, and Sm-B/B′, U1 snRNPA (U1A) and U1-70kDa autoantigens. The results are in accordance with the clustering of the predicted HLA class-I and class-II epitopes in protein parts which encompass the consensus of ordered regions, determined by individual disorder predictors. Some HLA class-II epitopes and linear B-cell epitopes were located near the segments predicted to have elevated crystallographic B factor in EBNA-1, Sm-B/B′ and U1 snRNP A proteins, suggesting that protein flexibility could influence the structural availability of epitopes. Naturally processed T-cell epitopes and linear B-cell epitopes could also be found within putative disordered binding sites, determined by “dips” in the prevalently disordered parts of prediction profiles of the majority of disorder predictors, and peaks in ANCHOR-prediction profile. Two minor antigenic regions within EBNA-1, mapped to the residues 58–85 and 398–458, encompassing putative disordered binding sites, contain epitopes connected with anti-Ro 60kDa and anti-Sm B/B′ autoimmunity in systemic lupus erythematosus. One of these regions overlaps residues 395–450, identified as the binding site of USP7 (HAUSP), which regulates the EBNA-1 replication function. In Sm-B/B′, one of the putative disordered binding sites (residues 114–165) encompasses the T-cell epitope 136–153, while another, residues 200–216, flanks two proline-rich B-cell epitopes (residues 190–198 and 216–222), overlapping the preferred CD2BP2–GYF-binding motif (R/K/G)XXPPGX(R/K), characteristic of splicosomal proteins. We have noticed that the same motif (residues 397–403) is mimicked in EBNA-1 and overlaps epitope 398–404, involved in anti-Sm B/B′ autoimmunity. The majority of recognized T- and B-cell epitopes in analyzed autoantigens or tumor-associated antigens appertain to the ordered or transient protein structures. The congruence between certain B- and T-cell epitopes and predicted disordered binding sites or protein-binding eukaryotic motifs in the antigens participating in molecular complexes might influence the capture of antigens, their processing and subsequent presentation and immunodominance.
[Display omitted]</description><identifier>ISSN: 0022-1759</identifier><identifier>EISSN: 1872-7905</identifier><identifier>DOI: 10.1016/j.jim.2014.03.027</identifier><identifier>PMID: 24726865</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Antigens, Neoplasm - chemistry ; Antigens, Neoplasm - metabolism ; Autoimmunity ; B-Lymphocytes - immunology ; Cancer ; Disorder prediction ; Disordered binding sites ; Epitope Mapping - methods ; Epitope structural availability ; Epitopes, B-Lymphocyte - chemistry ; Epitopes, B-Lymphocyte - metabolism ; Epitopes, T-Lymphocyte - chemistry ; Epitopes, T-Lymphocyte - metabolism ; Epstein-Barr virus ; Epstein-Barr Virus Nuclear Antigens - chemistry ; Epstein-Barr Virus Nuclear Antigens - metabolism ; HLA Antigens - metabolism ; Humans ; Immunity, Cellular ; Lupus Erythematosus, Systemic - immunology ; Male ; Neoplasm Proteins - chemistry ; Neoplasm Proteins - metabolism ; Peptides - chemistry ; Peptides - metabolism ; Phosphoproteins - chemistry ; Phosphoproteins - metabolism ; Protein Binding ; Protein Conformation ; Ribonucleoprotein, U1 Small Nuclear - chemistry ; Ribonucleoprotein, U1 Small Nuclear - metabolism ; Structure-Activity Relationship ; T-cell epitope prediction ; T-Lymphocytes - immunology ; Testicular Neoplasms - immunology ; Trans-Activators - chemistry ; Trans-Activators - metabolism</subject><ispartof>Journal of immunological methods, 2014-05, Vol.407, p.90-107</ispartof><rights>2014 Elsevier B.V.</rights><rights>Copyright © 2014 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c386t-3526b37e1bdeed73b746599c7329bd642dbd17e5fa14a0b262212af757794ee93</citedby><cites>FETCH-LOGICAL-c386t-3526b37e1bdeed73b746599c7329bd642dbd17e5fa14a0b262212af757794ee93</cites><orcidid>0000-0002-1802-5594</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jim.2014.03.027$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24726865$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pavlovic, Mirjana D</creatorcontrib><creatorcontrib>Jandrlic, Davorka R</creatorcontrib><creatorcontrib>Mitic, Nenad S</creatorcontrib><title>Epitope distribution in ordered and disordered protein regions. Part B — Ordered regions and disordered binding sites are targets of T- and B-cell immunity</title><title>Journal of immunological methods</title><addtitle>J Immunol Methods</addtitle><description>Intrinsically disordered proteins exist in highly flexible conformational states linked to different protein functions. In this work, we have presented evidence that HLA class-I- and class-II-binding T-cell epitopes, experimentally verified in several tumor-associated antigens and nuclear systemic autoantigens, are predominantly located in ordered protein regions or at disorder/order borderlines, defined by the majority of analyzed publicly available disorder predictors. We have also observed the overlapping of secondary structural elements and prevalently hydrophobic regions with T-cell epitopes in Epstein Barr Virus (EBV) nuclear antigen 1 (EBNA-1), cancer/testis antigen MAGE-A4, and Sm-B/B′, U1 snRNPA (U1A) and U1-70kDa autoantigens. The results are in accordance with the clustering of the predicted HLA class-I and class-II epitopes in protein parts which encompass the consensus of ordered regions, determined by individual disorder predictors. Some HLA class-II epitopes and linear B-cell epitopes were located near the segments predicted to have elevated crystallographic B factor in EBNA-1, Sm-B/B′ and U1 snRNP A proteins, suggesting that protein flexibility could influence the structural availability of epitopes. Naturally processed T-cell epitopes and linear B-cell epitopes could also be found within putative disordered binding sites, determined by “dips” in the prevalently disordered parts of prediction profiles of the majority of disorder predictors, and peaks in ANCHOR-prediction profile. Two minor antigenic regions within EBNA-1, mapped to the residues 58–85 and 398–458, encompassing putative disordered binding sites, contain epitopes connected with anti-Ro 60kDa and anti-Sm B/B′ autoimmunity in systemic lupus erythematosus. One of these regions overlaps residues 395–450, identified as the binding site of USP7 (HAUSP), which regulates the EBNA-1 replication function. In Sm-B/B′, one of the putative disordered binding sites (residues 114–165) encompasses the T-cell epitope 136–153, while another, residues 200–216, flanks two proline-rich B-cell epitopes (residues 190–198 and 216–222), overlapping the preferred CD2BP2–GYF-binding motif (R/K/G)XXPPGX(R/K), characteristic of splicosomal proteins. We have noticed that the same motif (residues 397–403) is mimicked in EBNA-1 and overlaps epitope 398–404, involved in anti-Sm B/B′ autoimmunity. The majority of recognized T- and B-cell epitopes in analyzed autoantigens or tumor-associated antigens appertain to the ordered or transient protein structures. The congruence between certain B- and T-cell epitopes and predicted disordered binding sites or protein-binding eukaryotic motifs in the antigens participating in molecular complexes might influence the capture of antigens, their processing and subsequent presentation and immunodominance.
[Display omitted]</description><subject>Antigens, Neoplasm - chemistry</subject><subject>Antigens, Neoplasm - metabolism</subject><subject>Autoimmunity</subject><subject>B-Lymphocytes - immunology</subject><subject>Cancer</subject><subject>Disorder prediction</subject><subject>Disordered binding sites</subject><subject>Epitope Mapping - methods</subject><subject>Epitope structural availability</subject><subject>Epitopes, B-Lymphocyte - chemistry</subject><subject>Epitopes, B-Lymphocyte - metabolism</subject><subject>Epitopes, T-Lymphocyte - chemistry</subject><subject>Epitopes, T-Lymphocyte - metabolism</subject><subject>Epstein-Barr virus</subject><subject>Epstein-Barr Virus Nuclear Antigens - chemistry</subject><subject>Epstein-Barr Virus Nuclear Antigens - metabolism</subject><subject>HLA Antigens - metabolism</subject><subject>Humans</subject><subject>Immunity, Cellular</subject><subject>Lupus Erythematosus, Systemic - immunology</subject><subject>Male</subject><subject>Neoplasm Proteins - chemistry</subject><subject>Neoplasm Proteins - metabolism</subject><subject>Peptides - chemistry</subject><subject>Peptides - metabolism</subject><subject>Phosphoproteins - chemistry</subject><subject>Phosphoproteins - metabolism</subject><subject>Protein Binding</subject><subject>Protein Conformation</subject><subject>Ribonucleoprotein, U1 Small Nuclear - chemistry</subject><subject>Ribonucleoprotein, U1 Small Nuclear - metabolism</subject><subject>Structure-Activity Relationship</subject><subject>T-cell epitope prediction</subject><subject>T-Lymphocytes - immunology</subject><subject>Testicular Neoplasms - immunology</subject><subject>Trans-Activators - chemistry</subject><subject>Trans-Activators - metabolism</subject><issn>0022-1759</issn><issn>1872-7905</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc1u1DAUhS0EokPhAdggL9kkXNuJHYsVrcqPVKldlLVlxzcjjybJYDtI3fUh2PJyPAmezpRFF2V1ZZ3vHN3rQ8hbBjUDJj9s6k0Yaw6sqUHUwNUzsmKd4pXS0D4nKwDOK6ZafUJepbQBAAYSXpIT3iguO9muyO-LXcjzDqkPKcfglhzmiYaJztFjRE_t5Pfaw3MX54xFjrguYKrptY2ZntE_d7_o1ZE5ao-tLkw-TGuaQsYiRqTZxjXmROeB3lT3-FnV43ZLwzguU8i3r8mLwW4TvjnOU_L988XN-dfq8urLt_NPl1UvOpkr0XLphELmPKJXwqlGtlr3SnDtvGy4d54pbAfLGguOS84Zt4NqldINohan5P0ht5z3Y8GUzRjSfhM74bwkw5QSHZdCyv-jLdddwzSIgrID2sc5pYiD2cUw2nhrGJh9gWZjSoFmX6ABYUqBxfPuGL-4Ef0_x0NjBfh4ALD8x8-A0aQ-4NSjDxH7bPwcnoj_C6WOrZ4</recordid><startdate>20140501</startdate><enddate>20140501</enddate><creator>Pavlovic, Mirjana D</creator><creator>Jandrlic, Davorka R</creator><creator>Mitic, Nenad S</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7T5</scope><scope>H94</scope><orcidid>https://orcid.org/0000-0002-1802-5594</orcidid></search><sort><creationdate>20140501</creationdate><title>Epitope distribution in ordered and disordered protein regions. Part B — Ordered regions and disordered binding sites are targets of T- and B-cell immunity</title><author>Pavlovic, Mirjana D ; Jandrlic, Davorka R ; Mitic, Nenad S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c386t-3526b37e1bdeed73b746599c7329bd642dbd17e5fa14a0b262212af757794ee93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Antigens, Neoplasm - chemistry</topic><topic>Antigens, Neoplasm - metabolism</topic><topic>Autoimmunity</topic><topic>B-Lymphocytes - immunology</topic><topic>Cancer</topic><topic>Disorder prediction</topic><topic>Disordered binding sites</topic><topic>Epitope Mapping - methods</topic><topic>Epitope structural availability</topic><topic>Epitopes, B-Lymphocyte - chemistry</topic><topic>Epitopes, B-Lymphocyte - metabolism</topic><topic>Epitopes, T-Lymphocyte - chemistry</topic><topic>Epitopes, T-Lymphocyte - metabolism</topic><topic>Epstein-Barr virus</topic><topic>Epstein-Barr Virus Nuclear Antigens - chemistry</topic><topic>Epstein-Barr Virus Nuclear Antigens - metabolism</topic><topic>HLA Antigens - metabolism</topic><topic>Humans</topic><topic>Immunity, Cellular</topic><topic>Lupus Erythematosus, Systemic - immunology</topic><topic>Male</topic><topic>Neoplasm Proteins - chemistry</topic><topic>Neoplasm Proteins - metabolism</topic><topic>Peptides - chemistry</topic><topic>Peptides - metabolism</topic><topic>Phosphoproteins - chemistry</topic><topic>Phosphoproteins - metabolism</topic><topic>Protein Binding</topic><topic>Protein Conformation</topic><topic>Ribonucleoprotein, U1 Small Nuclear - chemistry</topic><topic>Ribonucleoprotein, U1 Small Nuclear - metabolism</topic><topic>Structure-Activity Relationship</topic><topic>T-cell epitope prediction</topic><topic>T-Lymphocytes - immunology</topic><topic>Testicular Neoplasms - immunology</topic><topic>Trans-Activators - chemistry</topic><topic>Trans-Activators - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pavlovic, Mirjana D</creatorcontrib><creatorcontrib>Jandrlic, Davorka R</creatorcontrib><creatorcontrib>Mitic, Nenad S</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Journal of immunological methods</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pavlovic, Mirjana D</au><au>Jandrlic, Davorka R</au><au>Mitic, Nenad S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Epitope distribution in ordered and disordered protein regions. Part B — Ordered regions and disordered binding sites are targets of T- and B-cell immunity</atitle><jtitle>Journal of immunological methods</jtitle><addtitle>J Immunol Methods</addtitle><date>2014-05-01</date><risdate>2014</risdate><volume>407</volume><spage>90</spage><epage>107</epage><pages>90-107</pages><issn>0022-1759</issn><eissn>1872-7905</eissn><abstract>Intrinsically disordered proteins exist in highly flexible conformational states linked to different protein functions. In this work, we have presented evidence that HLA class-I- and class-II-binding T-cell epitopes, experimentally verified in several tumor-associated antigens and nuclear systemic autoantigens, are predominantly located in ordered protein regions or at disorder/order borderlines, defined by the majority of analyzed publicly available disorder predictors. We have also observed the overlapping of secondary structural elements and prevalently hydrophobic regions with T-cell epitopes in Epstein Barr Virus (EBV) nuclear antigen 1 (EBNA-1), cancer/testis antigen MAGE-A4, and Sm-B/B′, U1 snRNPA (U1A) and U1-70kDa autoantigens. The results are in accordance with the clustering of the predicted HLA class-I and class-II epitopes in protein parts which encompass the consensus of ordered regions, determined by individual disorder predictors. Some HLA class-II epitopes and linear B-cell epitopes were located near the segments predicted to have elevated crystallographic B factor in EBNA-1, Sm-B/B′ and U1 snRNP A proteins, suggesting that protein flexibility could influence the structural availability of epitopes. Naturally processed T-cell epitopes and linear B-cell epitopes could also be found within putative disordered binding sites, determined by “dips” in the prevalently disordered parts of prediction profiles of the majority of disorder predictors, and peaks in ANCHOR-prediction profile. Two minor antigenic regions within EBNA-1, mapped to the residues 58–85 and 398–458, encompassing putative disordered binding sites, contain epitopes connected with anti-Ro 60kDa and anti-Sm B/B′ autoimmunity in systemic lupus erythematosus. One of these regions overlaps residues 395–450, identified as the binding site of USP7 (HAUSP), which regulates the EBNA-1 replication function. In Sm-B/B′, one of the putative disordered binding sites (residues 114–165) encompasses the T-cell epitope 136–153, while another, residues 200–216, flanks two proline-rich B-cell epitopes (residues 190–198 and 216–222), overlapping the preferred CD2BP2–GYF-binding motif (R/K/G)XXPPGX(R/K), characteristic of splicosomal proteins. We have noticed that the same motif (residues 397–403) is mimicked in EBNA-1 and overlaps epitope 398–404, involved in anti-Sm B/B′ autoimmunity. The majority of recognized T- and B-cell epitopes in analyzed autoantigens or tumor-associated antigens appertain to the ordered or transient protein structures. The congruence between certain B- and T-cell epitopes and predicted disordered binding sites or protein-binding eukaryotic motifs in the antigens participating in molecular complexes might influence the capture of antigens, their processing and subsequent presentation and immunodominance.
[Display omitted]</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>24726865</pmid><doi>10.1016/j.jim.2014.03.027</doi><tpages>18</tpages><orcidid>https://orcid.org/0000-0002-1802-5594</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-1759 |
ispartof | Journal of immunological methods, 2014-05, Vol.407, p.90-107 |
issn | 0022-1759 1872-7905 |
language | eng |
recordid | cdi_proquest_miscellaneous_1773826366 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
subjects | Antigens, Neoplasm - chemistry Antigens, Neoplasm - metabolism Autoimmunity B-Lymphocytes - immunology Cancer Disorder prediction Disordered binding sites Epitope Mapping - methods Epitope structural availability Epitopes, B-Lymphocyte - chemistry Epitopes, B-Lymphocyte - metabolism Epitopes, T-Lymphocyte - chemistry Epitopes, T-Lymphocyte - metabolism Epstein-Barr virus Epstein-Barr Virus Nuclear Antigens - chemistry Epstein-Barr Virus Nuclear Antigens - metabolism HLA Antigens - metabolism Humans Immunity, Cellular Lupus Erythematosus, Systemic - immunology Male Neoplasm Proteins - chemistry Neoplasm Proteins - metabolism Peptides - chemistry Peptides - metabolism Phosphoproteins - chemistry Phosphoproteins - metabolism Protein Binding Protein Conformation Ribonucleoprotein, U1 Small Nuclear - chemistry Ribonucleoprotein, U1 Small Nuclear - metabolism Structure-Activity Relationship T-cell epitope prediction T-Lymphocytes - immunology Testicular Neoplasms - immunology Trans-Activators - chemistry Trans-Activators - metabolism |
title | Epitope distribution in ordered and disordered protein regions. Part B — Ordered regions and disordered binding sites are targets of T- and B-cell immunity |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T04%3A57%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Epitope%20distribution%20in%20ordered%20and%20disordered%20protein%20regions.%20Part%20B%20%E2%80%94%20Ordered%20regions%20and%20disordered%20binding%20sites%20are%20targets%20of%20T-%20and%20B-cell%20immunity&rft.jtitle=Journal%20of%20immunological%20methods&rft.au=Pavlovic,%20Mirjana%20D&rft.date=2014-05-01&rft.volume=407&rft.spage=90&rft.epage=107&rft.pages=90-107&rft.issn=0022-1759&rft.eissn=1872-7905&rft_id=info:doi/10.1016/j.jim.2014.03.027&rft_dat=%3Cproquest_cross%3E1529841903%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1529841903&rft_id=info:pmid/24726865&rft_els_id=S0022175914001161&rfr_iscdi=true |